METHOD DEVELOPMENT AND VALIDATION OF IRBESARTAN CHLORTHALIDONE AND CILNIDIPINE IN THEIR COMBINED TABLET DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

  • Rishabh K Dagariya Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan
  • Rakesh K Jat Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan
DOI https://doi.org/10.22270/jddt.v7i4.1471

Abstract

The present work describes a validated reverse phase high performance liquid chromatographic method for simultaneous estimation of Irbesartan chlorthalidone and cilnidipine in tablet dosage form. The quantification was carried out using C18 column (250 x 4.6mm, 5μm) and mobile phase comprised of Buffer, Acetonitrile and TEA in a proportion of 80:20:0.1 %v/v/v. The flow rate was 1.0 ml/min and the eluent was monitored at 222 nm. The selected chromatographic conditions were found to effectively separate Irbesartan Chlorthalidone and cilnidipine were 3.807 min, 4.667 min, and 6.887 min respectively. Linearity was found to be in the range of 30-90 μg/ml, 1.25-3.75 μg/ml and 1-3 μg/ml for Irbesartan Chlorthalidone and cilnidipine respectively. The percentage recoveries of all the drugs were found to be 99.27-99.81%, 99.57-99.99% and 99.22-99.44% for Irbesartan, chlorthalidone, and cilnidipine. The proposed method was found to be fast, accurate, precise, and reproducible and can be used for simultaneous estimation of these drugs in a tablet.

Downloads

Download data is not yet available.

Author Biographies

Rishabh K Dagariya, Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan

Ph.D. Research Scholar, Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan, India

 

Rakesh K Jat, Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan

Director cum Principal, Institute of Pharmacy, Shri Jagadish Prasad Jhabarmal Tibrewala University, Jhunjhunu, Rajasthan, India

References

1. “Drug profile for Chlorthalidone”, Sep 2015, http://www.drugbank.ca/drugs/DB00310
2. “Drug profile for Chlorthalidone”, Sep 2015,http://en.wikipedia.org/wiki/ Chlorthalidone
3. “Drug profile for Cilnidipine”, Sep 2015, en.wikipedia.org/wiki/Cilnidipine.
4. “Drug profile for Cilnidipine”, Sep 2015, www.drugbank.ca/drugs/DB03614
5. Niraimathi V, Jerad SA, Kumar SI. Uv Spectrophotometric Methods For The Estimation OF Chlorthalidone In Bulk and Oral Dosage Form. Indo American J. Pharm,2013; 3(9):7160-7167.
6. Rang and Del’s Pharmacology; 6th Edn; Churchil levingstone Publishers (P) Ltd, New York, 2004, pp 277-285.
7. Dong WM. Modern HPLC for Practicing Scientists; A Wiley- Inter science publication, USA, 2006, pp 1-9.
8. Kazakevich Y and LoBrutto R. HPLC for pharmaceutical Scientists; A John Wiley and sons, 2007, pp 1-6.
9. Mhaske RA, Sahsrabhdhe S, mhaske AA, “RP-HPLC Method For Simultataneous Determination of Irbesartan, Losartan, Hydro-Chlorothiazide And Chlorthalidone–Application To Commercially Available Drug Products” Int. j. pharm. Sci. and res., 2014; 1116-1123
10. Gandla K, Rao JS, Kumar JR, “New Stability Indicating Validated RP-HPLC Method for Simultaneous Estimation of Irbesartan and Atorvastatin in Combined Tablet Dosage Forms” Ame. J. pharm. Tech. res., 2015; 5(4):380-390
11. Gandla K, Suthakaran R, Kandoji P, “Development and Validation of RP-HPLC Method for Simultaneous Estimation of Irbesartan and Simvastatin in Tablet Dosage Form” Ame. J. pharm. And health res., 2014; 2(10):199-205
12. Patel S, Patel D” Simultaneous Determination of Metoprolol Succinate And Chlorthalidone By UV Spectrophotometric Method.” Pharmagene. 2013; 1(3):39-43
13. Naazneen S, Sridevi A,” Stability-Indicating RP-HPLC Method For The Simultaneous Estimation of Azilsartan Medoxomil And Chlorthalidone In Solid Dosage Forms. ” Int. J. of Pharm. and Pharm. Sci. 2014; 6(6):236-243
14. Kalaiselvi P and Lalitha K G, “Development and Validation of RP-HPLC Method For The Simultaneous Estimation of Chlorthalidone And Irbesarton In Pharmaceutical Dosage Form.”Pharmacophore.2014; 5(2):279-286.
15. Lee KH, Park HJ, Shin CY, Myung CS “Pharmaceutical composition comprising cilnidipine and telmisartan”, European Patents, PCT/KR2009/002539, 2010
Statistics
840 Views | 484 Downloads
How to Cite
1.
Dagariya R, Jat R. METHOD DEVELOPMENT AND VALIDATION OF IRBESARTAN CHLORTHALIDONE AND CILNIDIPINE IN THEIR COMBINED TABLET DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. JDDT [Internet]. 15Jul.2017 [cited 19May2022];7(4):88-6. Available from: http://jddtonline.info/index.php/jddt/article/view/1471
Issue
Vol 7 No 4 (2017): Volume 7, Issue 4, July-August 2017
Section
Research

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).